The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 2-17B Pediatric Hematology

Sat. Oct 12, 2019 10:10 AM - 11:10 AM No.17 (Tokyo International Forum, 4F G407)

Chair: Mariko Eguchi (Department of Pediatrics, Ehime University Graduate School of Medicine)

Ryota Shirai1, Yoko Shioda3, Kenichi Sakamoto3, Tomoo Osumi1,3, Yuji Yamada1, Masanori Yoshida1,2, Kaoru Yoshida1, Daisuke Tomizawa3, Kimikazu Matsumoto3, Nobutaka Kiyokawa1, Takako Yoshioka4, Motohiro Kato1,3 (1.Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa Japan, 3.Children Cancer Center, NCCHD, Tokyo, Japan, 4.Pathology, NCCHD, Tokyo, Japan)

Shinsuke Hirabayashi1, Takahiko Yasuda2, Masashi Sanada2, Hiroyoshi Hattori2, Dai Nishijima2, Hiroki Kurahashi3, Yuichi Shiraishi4, Matsuo Yamamoto2, Akiko Saito2, Motohiro Kato5, Hideki Muramatsu6, Tadashi Kumamo7, Hiroaki Goto8, Ryoji Kobayashi9, Souichi Adachi10, Satoru Miyano11, Seishi Ogawa12, Keizo Horibe2, Atsushi Manabe1,13 (1.Department of Pediatrics, St Luke's International Hospital, Tokyo, Japan, 2.Clinical Research Center, Nagoya Medical Center, 3.Department of Molecular Genetics, Fujita Health University, 4.Center for Cancer Genomics and Advanced Therapeutics, National Cancer Center, 5.National Research Institute for Child Health and Development, 6.Department of Pediatrics, Nagoya University Graduate School of Medicine, 7.Department of Pediatric Oncology, National Cancer Center Hospital, 8.Division of Hematology/Oncology, Kanagawa Children's Medical Center, 9.Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, 10.Departments of Human Health Science, Kyoto University, 11.Human Genome Center, Institute of Medical Science, University of Tokyo, 12.Department of Pathology and Tumor Biology, Kyoto University, 13.Department of Pediatrics, Hokkaido University Graduate School of Medicine)

Lika'a F. Al-Kzayer1, Yusuke Okuno2, Kazuo Sakashita1,3, Mazin F. Al-Jadiry4, Raghad M. Saeed4, Salma Al-Hadad4, Hussam M. Al-Abdullah5, Kenichi Koike1,6, Yozo Nakazawa1 (1.Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan, 2.Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Nagoya, Japan, 3.Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Nagano, Japan, 4.Department of Pediatric, College of Medicine, Baghdad University, Baghdad Medical City, Baghdad, Republic of Iraq, 5.Department of Pediatric Oncology, Basra Children's Specialty Hospital, Basra, Basra, Republic of Iraq, 6.Shinonoi General Hospital, Minami Nagano Center, Nagano, Nagano, Japan)

Yoko Nishinaka1, Akira Niwa1, Shiori Matsuo1, Yasuhiro Kazuki2,3, Yuuna Yakura2, Takehiko Hiroma4, Tsutomu Toki5, Tetsushi Sakuma6, Takashi Yamamoto6, Etsuro Ito5, Mitsuo Oshimura2, Tatsutoshi Nakahata7, Megumu Saito1 (1.Clinical Application, CiRA, Kyoto Univ., Kyoto, Japan, 2.Choromosome Engineering Research Center, Tottori Univ., Tottori, Japan, 3.Biomedical Science, Regenerative Medicine and Biofunction, Tottori Univ., Tottori, Japan, 4.Perinatal Medical Center, Nagano Children's Hospital, NAgano, Japan, 5.Pediatrics, Hirosaki Univ., Hirosaki, Japan, 6.Integrated Sciences for Life, Hiroshima Univ., Hiroshima, Japan, 7.Drug Discovery Technology Development Office, CiRA, Kyoto Univ., Kyoto, Japan)